title: Delayed elimination of methotrexate in a patient receiving ciprofloxacin.
authors.forename: Imen
authors.initials: I
authors.lastname: Aouinti
authors.forename: Emna
authors.initials: E
authors.lastname: Gaïes
authors.forename: Sameh
authors.initials: S
authors.lastname: Trabelsi
authors.forename: Issam
authors.initials: I
authors.lastname: Salouage
authors.forename: Nadia
authors.initials: N
authors.lastname: Jebabli
authors.forename: Rim
authors.initials: R
authors.lastname: Charfi
authors.forename: Mohamed
authors.initials: M
authors.lastname: Lakhal
authors.forename: Anis
authors.initials: A
authors.lastname: Klouz
mesh_terms: D000293:Adolescent; D000964:Antimetabolites, Antineoplastic / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004347:Drug Interactions; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007683:Kidney Tubular Necrosis, Acute / Q000139:chemically induced / Q000378:metabolism; D002955:Leucovorin / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D026901:Membrane Transport Proteins / Q000378:metabolism; D008657:Metabolic Clearance Rate; D008727:Methotrexate / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011001:Pleuropneumonia / Q000150:complications / Q000188:drug therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy*
chemical_list: D000964:Antimetabolites, Antineoplastic; D026901:Membrane Transport Proteins; D002939:Ciprofloxacin; D002955:Leucovorin; D008727:Methotrexate